IMS enjoys a long-standing relationship with physician partners throughout the world. These physicians participate on IMS panels and research studies that help advance the quality of healthcare in a variety of ways. Among the benefits:
Together with our physician partners, we look at the patient/prescriber landscape: what’s being prescribed and when, influencing factors, how drugs are prescribed and -- importantly -- why they're prescribed. We examine the relationship between diseases and treatments, and between drugs and diagnoses. From assessing the impact of drug launches on treatment patterns to identifying new uses for existing therapies, our insights and intelligence help pharmaceutical clients, healthcare institutions and prescribers make better decisions.
Our medical audits, available in more than 50 countries, are an unparalleled tool for analyzing diagnoses and treatment patterns across physician specialties and different geographies. With them, our customers can better balance their R&D resources, gain insights into physician behaviors, and develop the right sales and market entry strategies.
IMS’s responsibility to the physician community extends to the healthcare research arena, where we provide researchers with access to our information assets.
